205. Hormone Therapy Position Statement of The North American Menopause Society

You Are Not Broken

Kelly Casperson, MD

Medicine, Health & Fitness

5 • 743 Ratings

🗓️ 2 April 2023

⏱️ 53 minutes

🔗️ Recording | iTunes | RSS

🧾️ Download transcript

Summary

Here is the 2022 NAMS Hormone Therapy Position Statement! https://www.menopause.org/docs/default-source/professional/nams-2022-hormone-therapy-position-statement.pdf 1) For women aged younger than sixty years or who are within ten years of menopause onset and have no contra indications the benefit risk ratio is favorable for treatment of bother some vasomotor symptoms and prevention of bone loss for women who initiate hormone therapy more than ten years from menopause onset. 2) We discuss safety 3) We discuss decreased mortality in women 50-60 in the WHI trial. 4) We discuss the absolute risk reduction for: all cause mortality, fracture, diabetes, and breast cancer in women aged younger than sixty years 5) Their statement on compounded and pelleted hormones 6) Vasomotor symptoms are assoicated with diminished sleep quality and reduced quality of life 7) Hormones for genitourinary syndrome of menopause 8) We discuss cognition and weight gain 9) The critical window or "healthy cell" hypothesis Did you get the You Are Not Broken Book Yet? https://amzn.to/3p18DfK Join my membership to get these episodes ASAP when they are created and without advertisement and even listen live to the interviews and episodes. www.kellycaspersonmd.com/membership --- Send in a voice message: https://podcasters.spotify.com/pod/show/kj-casperson/message Learn more about your ad choices. Visit megaphone.fm/adchoices

Transcript

Click on a timestamp to play from that location

0:00.0	You are listening to You Are Not Broken, the only podcast that combines science, medicine, and psychology to re-educate your brain and help you live your best love life. And I'm your host, Ford certified female urologist, Dr. Kelly Kasperson.
0:16.3	Hey, everybody, it's Kelly. Welcome back. I am so excited finally to be reading you the NAMS position
0:22.7	statement, the 2022 hormone therapy position statement of the North American Menopause Society. So,
0:28.6	pretty excited to finally read this to you. This is a document that, as it says, came out in 2022.
0:34.8	It has like a 20-page document. I'm not going to read it verbatim,
0:40.8	but I'm going to read the important stuff. I'm going to try to. I'm going to see. I don't know
0:44.7	if I'm going to put my personal opinion in here or not, but so many people ask like,
0:48.9	what do I bring to my doctor or where are these guidelines, whenever I cite something on Instagram and I want to be
0:57.4	able to say, hey, go to this episode, just listen to this when you're in the car so you understand
1:02.7	the guidelines. You can send people to this episode. Now you have it in audio form. Otherwise,
1:07.5	go to North American Menopause Society. It's in the journal Menopause,
1:12.8	the journal of the North American Menopause Society, volume 29, number seven, page 767 to 794,
1:19.6	coming out in 2022. So this is currently the most up-to-date document on their position statement.
1:28.8	So, drum roll, here we go.
1:31.8	Hormone therapy remains the most effective treatment for basal motor symptoms and the
1:35.9	generally urinary syndrome of menopause and has been shown to prevent bone loss and fracture.
1:41.0	I'm kind of reading the important stuff in the abstract right now.
1:45.3	For women aged younger than 60 years or who are within 10 years of menopause onset and have no contraindications,
1:52.0	the benefit risk ratio is favorable for treatment of bothersome basal motor symptoms and prevention
1:56.8	of bone loss. For women who initiate hormone therapy more than 10 years from menopause onset or who
2:02.1	are aged older than 60, the benefit risk ratio appears less favorable because of the greater
2:07.6	absolute risks of coronary heart disease, stroke, venous thromboat embolism, which is a blood clot, and
	...

Please login to see the full transcript.

Previous episode | Next episode

Disclaimer: The podcast and artwork embedded on this page are from Kelly Casperson, MD, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of Kelly Casperson, MD and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.